Skip to content
Stock overview

OSCR · Oscar Health, Inc.

Is OSCR setting up for a breakout, what are traders on X and the news saying, are its insiders buying, and how is the business doing? Everything Raspberry Trades measures on Oscar Health, Inc., in one place.

Today's breakout radar

Is OSCR setting up for a breakout?

Breakout Radar API →

OSCR reports earnings on Nov 5, 2026 — a breakout right before a report can reverse on the numbers.

Not today. OSCR is not on today's radar: no tight base just under a resistance that has been tested again and again.

The radar showed OSCR on Oct 16, 2026 at $31.89, 6.7% under its $34.02 pivot. Since then: Failed (lost the base). See that setup →

See the stocks that are setting up today →

What are traders on X saying about OSCR?

Stock Sentiment API →
Bullish
Overall
21
Bullish posts
5
Bearish posts
40
Posts read

Bulls: Q2 showed $362M profit versus a $228M loss a year earlier, with members up 46% to 2.96M, and 1H profit of $1.04B; the stock has run from $11 to $34 and was up another 60% since one poster's earlier note. Sector read-through is strong: healthcare earnings are 6-for-6 beats ($UNH, $ELV, $MOH, $CNC, $HCA, $JNJ), UNH's MLR came in at 88.4% vs 89.9% expected, and CNC raised guidance — a call one poster called 'VERY positive for the $OSCR.' Earnings land Nov 5 with open enrollment five days later, and one bull frames 2026 guidance as $19B revenue and $800M EBIT (21% tax rate, $632M earnings, 333M shares, $10.3B market cap at $30.99), with a technical target of $44–$49 (wave 5) versus $20–$22 (wave 4).

Bears: Technically the stock has formed a rising wedge that 'usually marks the local top' — one investor who has held since $12 began trimming around $33, and another sees a potential reversal with the 100sma breaking toward the 200sma and 0.5 fib at $23. Price has been sideways for months rather than in a real uptrend, with a pullback expected toward $20, and relative-strength names including OSCR are building bearish divergences; the stock is $31 now versus $33 at end-June. One poster also flags 2025 reported EPS of -1.69 vs -1.27 estimated (-33.01%) and revenue of $11.47B vs $11.97B estimated (-4.21%).

Reading from Oct 28, 2026; each post classified by AI, weighted by engagement.

X sentiment, day by day (30 days measured)Sentiment History API →
Sep 29, 2026above the line = more bullish than bearishOct 28, 2026

What is the news saying about OSCR?

News Sentiment API →

No recent news reading for OSCR. The News Sentiment API reads today's headlines on any US stock.

Are OSCR insiders buying or selling?

Insider Trading API →
$0
Bought, last 3 months
$24.2M
Sold, last 3 months
$11.9M
Bought, 12 months
$66.8M
Sold, 12 months

Open-market trades only, from SEC Form 4 filings — option exercises, tax withholding and grants are left out.

  • Sold · WITTMAN VANESSA AMES$806K · Sep 18, 2026
  • Sold · Schlosser Mario$4.6M · Aug 28, 2026
  • Sold · Schlosser Mario$18.2M · Aug 27, 2026
  • Sold · Blackley Richard Scott$595K · Aug 18, 2026
  • Sold · Schlosser Mario$957K · Jul 1, 2026
Every OSCR insider trade →

How is Oscar Health, Inc.'s business doing?

Financial Statements API →
Quarter endedRevenuevs year beforeNet incomeEPS
Jun 30, 2026$6.1M-6%$361.8M$1.10
Mar 31, 2026$5.7M+32%$679.0M$2.07
Sep 30, 2025$8.8M+80%−$137.4M$-0.53
Jun 30, 2025$6.5M+24%−$228.4M$-0.89

From the company's SEC filings (10-Q and 10-K).

What does Oscar Health, Inc. expect?

Company Guidance API →
  • Full Year 2026 · total revenue · 8-K filed Aug 6, 2026

    “Total Revenue (1) $18.7 billion $19.0 billion $18.7 billion $19.0 billion”

  • Full Year 2026 · total revenue · 8-K filed Feb 10, 2026

    “Total Revenue (1) $18.7 billion $19.0 billion”

  • Full Year 2026 · medical loss ratio · 8-K filed Feb 10, 2026

    “Medical Loss Ratio (2) 82.4% 83.4%”

  • Full Year 2025 · total revenue · 8-K filed Nov 6, 2025

    “Total Revenue (1) $12.0 billion $12.2 billion”

Quoted from the outlook the company filed with the SEC.

Get the best breakout setups every morning

Free account, no card: today's top 5 with charts, by email before the open.

Get the top 5 free

Measured data, not recommendations. Not investment advice.